Delivery Order SPE2DB20D3303-SPE2DB25FA2HZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,401.21 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units). This contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $7,054.82 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $4,628.35. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $5,968.23. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 11, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $50,589.89 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Carvedilol ER 80 mg capsules in quantities of 30 units, with a ceiling value of $10,871.76. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, representing a direct fulfillment of pharmaceutical needs for federal medical operations. The award carries no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count units) valued at $5,986.38 under a firm fixed price contract type. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $2,756.79 and an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing contract vehicle. The performance location is the company's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $28,718.73. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $6,612.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger federal contract...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2HZDelivery Order
The Defense Logistics Agency awarded a $4,710.22 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The parent contract demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements across multiple therapeutic domains and geographic regions for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 8/8/25 |